Renaissance Technologies
NMTR

Renaissance Technologies’s 9 Meters Biopharma NMTR Stock Holding History

Renaissance Technologies’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-15,180
Closed -$10K – 4298
2023
Q2 		$10K Buy
15,180
+855
+6% +$756 ﹤0.01% 3830
2023
Q1 		$20K Sell
14,325
-58,843
-80% -$111K ﹤0.01% 3825
2022
Q4 		$92K Sell
73,168
-9,942
-12% -$22.7K ﹤0.01% 3649
2022
Q3 		$357K Buy
83,110
+59,645
+254% +$296K ﹤0.01% 3117
2022
Q2 		$122K Sell
23,465
-88,890
-79% -$838K ﹤0.01% 3798
2022
Q1 		$1.35M Buy
+112,355
New +$1.53M ﹤0.01% 2525
2021
Q3 		– Sell
-65,251
Closed -$1.44M – 3966
2021
Q2 		$1.44M Buy
+65,251
New +$1.6M ﹤0.01% 2468
2021
Q1 		– Sell
-31,499
Closed -$541K – 3827
2020
Q4 		$541K Buy
31,499
+14,612
+87% +$244K ﹤0.01% 2793
2020
Q3 		$275K Buy
16,887
+10,447
+162% +$127K ﹤0.01% 3027
2020
Q2 		$74K Sell
6,440
-4,830
-43% -$54.5K ﹤0.01% 3305
2020
Q1 		$113K Buy
11,270
+7,765
+222% +$97.4K ﹤0.01% 3206
2019
Q4 		$39K Buy
+3,505
New +$58.4K ﹤0.01% 3413

Other funds holding NMTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SIS
Strategic Investment Solutions Orland Park, Illinois $437M AUM 30.41% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
RFA
Register Financial Advisors Atlanta, Georgia $326M AUM 48.38% 1-Year Est. Return

Renaissance Technologies's NMTR Position: Q3 2023 in Review

Renaissance Technologies sold out of 9 Meters Biopharma (NMTR) in Q3 2023, closing a stake of 15,180 shares — an estimated $10K sold.

Renaissance Technologies first reported a position in NMTR in Q4 2019 and held it in 12 quarters. The position peaked at $1.44M in Q2 2021. 6 funds tracked by Wall St. Rank hold NMTR as of Q3 2023.

  • Renaissance Technologies reported no remaining 9 Meters Biopharma position as of Q3 2023 after selling out during the quarter.
  • Renaissance Technologies sold 15,180 9 Meters Biopharma shares in Q3 2023, an estimated $10K.
  • Renaissance Technologies first reported a position in 9 Meters Biopharma in Q4 2019 and held it in 12 quarters.
  • Renaissance Technologies's 9 Meters Biopharma position peaked at $1.44M in Q2 2021.
  • 6 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2023.

Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.